Samer A. Al'Hadidi, MD, MS, reviewed the benefits of cilta-cel in the subgroup analysis of CARTITUDE-4 in patients with ...
Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...
The FDA has granted orphan drug designation to namodenoson (CF102) in pancreatic cancer. Orphan drug designation provides Can ...
Jacob E. Berchuck, MD, discussed research behind using a blood-based liquid biopsy in prostate cancer and findings presented ...
Mirvetuximab soravtansine (Elahere) is an antibody-drug conjugate designed to treat ovarian cancer. It works by binding to folate receptor-alpha (FRα). This binding delivers a potent anticancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback